Mavoglurant in Alcohol Drinking
Mental Health & Behavioral Research
What is the purpose of this trial?
The purpose of this alcohol-interaction pilot study is to provide information on the effect of mavoglurant on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of 200 mg mavoglurant versus placebo on alcohol related responses. This is a between subjects double blind randomized design in which the investigators plan to run 14 subjects to obtain 10 completers.
- Ages21 years - 50 years
- Trial withNational Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Start Date10/09/2020
- End Date02/28/2022
- Last Updated07/15/2021
- Study HIC#2000021703